Journals / MN Oftalmoloji / 2018 / Cilt: 25 - Sayı: 3

Comparison of Short-Term Intraocular Pressure After Intravitreal Injection of Aflibercept and Ranibizumab in Age-Related Macular Degeneration Patients

Yaşa Bağlı Maküla Dejenerasyonu Hastalarında İntravitreal Aflibersept ve Ranibizumab Enjeksiyonu Sonrası Kısa Dönem Göz İçi Basıncının Karşılaştırılması

Pages
148–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Intravitreal aplication of ranibizumab caused higher short-term post-injection IOP increment with smaller post-injection conjunctival bleb diameter than aflibercept application.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Comparison of effect of intravitreal aflibercept and ranibizumab application on short-term intraocular pressure (IOP) in wet type age related macular degeneration (AMD) patients.
📊
Key Findings & Data:Material and Method: A total of 83 patients with neovascular age-related macular degeneration (83 eyes) who received intravitreal afliber- cept or ranibizumab were prospectively assessed for parameters like baseline demographic/clinical information, total number of aflibercept or ranibizumab injections, intraocular pressure measuretments before, after and 30 min after intravitreal injection and post-injection conjuncti- val bleb diameter due to vitreus reflux.
💡
Conclusion & Impact:Conclusions: Intravitreal aplication of ranibizumab caused higher short-term post-injection IOP increment with smaller post-injection conjunctival bleb diameter than aflibercept application.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Comparison of effect of intravitreal aflibercept and ranibizumab application on short-term intraocular pressure (IOP) in wet type age related macular degeneration (AMD) patients. Material and Method: A total of 83 patients with neovascular age-related macular degeneration (83 eyes) who received intravitreal afliber- cept or ranibizumab were prospectively assessed for parameters like baseline demographic/clinical information, total number of aflibercept or ranibizumab injections, intraocular pressure measuretments before, after and 30 min after intravitreal injection and post-injection conjuncti- val bleb diameter due to vitreus reflux. Results: Demographical and clinical parameters, total number of injections, intraocular pressure before and 30 min after intravitreal injec- tion did not significantly differ between aflibercept and ranibizumab groups (p values range between 0.081 and 0.840). Immediate postinjection intraocular pressure and diameter of conjunctival bleb differed significantly between groups (p values were0.006 and 0.004, respectively). Conclusions: Intravitreal aplication of ranibizumab caused higher short-term post-injection IOP increment with smaller post-injection conjunctival bleb diameter than aflibercept application.

Özet

Amaç: Yaş tip yaşa bağlı maküla dejenerasyonu hastalarında intravitreal aflibersept ve ranibizumab uygulamasının kısa dönem göz içi ba- sıncı üzerine etkisinin karşılaştırılması. Gereç ve Yöntem: Yaş tip yaşa bağlı maküla dejenerasyonu tanısıyla intravitreal aflibersept veya ranibizumab uygulanan 83 hastanın (83 göz) bazal demografik/klinik bilgileri, toplam aflibersept veya ranibizumab enjeksiyon sayısı, enjeksiyon öncesi, sonrası ve 30 dakika sonrası göz içi basıncı ve enjeksiyon sonrası vitreus reflüsüne bağlı gelişen konjonktival bleb çapı gibi parametreleri prospektif olarak değerlendiril- di. Bulgular: Aflibersept ve ranibizumab gruplarının demografik ve klinik parametreleri, toplam enjeksiyon sayısı, intravitreal enjeksiyon ön- cesi ve enjeksiyon sonrası 30. dakika göz içi basıncı değerleri arasında anlamlı fark saptanmadı (p değerleri aralığı 0,081 ve 0,840). Erken dönem post-enjeksiyon göz içi basıncı ve post-enjeksiyon vitreus reflüsüne bağlı gelişen konjonktival bleb çapı değerleri gruplar arasında an- lamlı düzeyde farklılık göstermekte idi. Sonuç: Yaş tip yaşa bağlı maküla dejenerasyonu olgularında intravitreal ranibizumab uygulaması aflibersept uygulamasına göre daha kü- çük post-enjeksiyon konjonktival bleb çapı ile birlikte daha yüksek enjeksiyon sonrası kısa dönem göz içi basıncı artışına neden olmaktadır.

🔖

Cite This Article

ULAŞ, F., UYAR, E., BAYRAM, T., DOĞAN, Ü. (2018). Comparison of Short-Term Intraocular Pressure After Intravitreal Injection of Aflibercept and Ranibizumab in Age-Related Macular Degeneration Patients. MN Oftalmoloji, Cilt: 25 - Sayı: 3, 148–151. https://ajindex.com/articles/295482

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Mojica G, Hariprasad SM, Jager RD, Mieler WF. Short-term in- traocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related mac- ular degeneration. Br J Ophthalmol 2008;92:584. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocu- lar pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008;146:930-4.
  2. Arikan G, Osman Saatci A, Hakan Oner F. Immediate intraocular pressure rise after intravitreal injection of ranibizumab and two doses of triamcinolone acetonide. Int J Ophthalmol 2011;4:402-5.
  3. Good TJ, Kimura AE, Mandava N, Kahook MY. Sustained eleva- tion of intraocular pressure after intravitreal injections of anti- VEGF agents. Br J Ophthalmol 2011;95:1111-4.
  4. Hoang QV, Mendonca LS, Della Torre KE, Jung JJ, Tsuang AJ, Freund KB. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor in- jections. Ophthalmology 2012;119:321-6.
  5. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 2007;42:807-11.
  6. Quigley HA, Anderson DR. Distribution of axonal transport blockade by acute intraocular pressure elevation in the primate optic nerve head. Invest Ophthalmol Vis Sci 1977;16:640-4.
  7. Michelson G, Groh MJ, Langhans M. Perfusion of the juxtapapil- lary retina and optic nerve head in acute ocular hypertension. Ger J Ophthalmol 1996;5:315-21.
  8. Pang CE, Mrejen S, Hoang QV, Sorenson JA, Freund KB. Association between Needle Size, Postinjection Reflux, and Intraocular Pressure Spikes after Intravitreal Injections. Retina 2015;35:1401-6.
  9. Knecht PB, Michels S, Sturm V, Bosch MM, Menke MN. Tunnelled versus straight intravitreal injection: intraocular pres- sure changes, vitreous reflux, and patient discomfort. Retina 2009;29:1175-81.